CAPTRUST Financial Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $594K | Buy |
38,440
+2,189
| +6% | +$33.8K | ﹤0.01% | 1625 |
|
|
2025
Q1 | $539K | Buy |
36,251
+18,817
| +108% | +$280K | ﹤0.01% | 1603 |
|
|
2024
Q4 | $231K | Sell |
17,434
-6,702
| -28% | -$88.7K | ﹤0.01% | 2068 |
|
|
2024
Q3 | $343K | Sell |
24,136
-1,966
| -8% | -$28K | ﹤0.01% | 1807 |
|
|
2024
Q2 | $338K | Sell |
26,102
-12,000
| -31% | -$155K | ﹤0.01% | 1741 |
|
|
2024
Q1 | $529K | Sell |
38,102
-18,225
| -32% | -$253K | ﹤0.01% | 1458 |
|
|
2023
Q4 | $804K | Sell |
56,327
-3,086
| -5% | -$44K | ﹤0.01% | 1405 |
|
|
2023
Q3 | $919K | Buy |
59,413
+26,849
| +82% | +$415K | ﹤0.01% | 1256 |
|
|
2023
Q2 | $512K | Buy |
32,564
+1,139
| +4% | +$17.9K | ﹤0.01% | 1611 |
|
|
2023
Q1 | $518K | Sell |
31,425
-5,106
| -14% | -$84.1K | ﹤0.01% | 1387 |
|
|
2022
Q4 | $570K | Buy |
36,531
+20,573
| +129% | +$321K | ﹤0.01% | 1267 |
|
|
2022
Q3 | $207K | Buy |
15,958
+3,553
| +29% | +$46.1K | ﹤0.01% | 1802 |
|
|
2022
Q2 | $174K | Buy |
12,405
+3,971
| +47% | +$55.7K | ﹤0.01% | 1790 |
|
|
2022
Q1 | $121K | Sell |
8,434
-7,167
| -46% | -$103K | ﹤0.01% | 2128 |
|
|
2021
Q4 | $213K | Buy |
15,601
+7,881
| +102% | +$108K | ﹤0.01% | 1597 |
|
|
2021
Q3 | $126K | Sell |
7,720
-1,084
| -12% | -$17.7K | ﹤0.01% | 1888 |
|
|
2021
Q2 | $148K | Buy |
8,804
+697
| +9% | +$11.7K | ﹤0.01% | 1743 |
|
|
2021
Q1 | $148K | Buy |
8,107
+1,985
| +32% | +$36.2K | ﹤0.01% | 1693 |
|
|
2020
Q4 | $111K | Buy |
6,122
+1,918
| +46% | +$34.8K | ﹤0.01% | 1460 |
|
|
2020
Q3 | $74K | Buy |
4,204
+1,152
| +38% | +$20.3K | ﹤0.01% | 1485 |
|
|
2020
Q2 | $54K | Buy |
+3,052
| New | +$54K | ﹤0.01% | 1599 |
|